FDA product approval
not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.
Research compound · identity guide · checked 2026-10-09
Cortexin
Cortexin is listed here as a identity guide. Named peptide-extract preparation; a heterogeneous extract is not a single defined peptide. Status was checked 2026-10-09. This card reports cited facts. It does not tell you to use Cortexin or how much to take.
Last checked Oct 9, 2026 by PepBear. Not medical advice.
- FDA product
- not established
- Compounding
- not established
- Research
- source limited
- Sport
- unknown
What is Cortexin?
Other names in the library: Cortexin 10mg — 10mg / Premium, Cortexin 10mg — 5mg (Out of stock) / Premium. Evidence describes the named substance, not a quality certification or equivalence assessment of commercial stock. Listed sizes: 5 mg, 10 mg. A seller title is a listing. It does not prove the vial matches a paper.
Named peptide-extract preparation; a heterogeneous extract is not a single defined peptide.
Regulatory status, dated 2026-10-09
Compounding
not established. Legal compounding eligibility is not established here. Sale or a supplement label does not establish eligibility.
Research
source limited. No matched controlled clinical study of this exact preparation was verified in this source audit.
Sport
unknown. Not individually verified against current sport rules. Check the exact ingredients with your sport authority.
What the cited papers actually measured
We mark the cited papers as D for No matched controlled clinical study of this exact preparation was verified in this source audit. and Identity and formulation must be established before interpreting efficacy claims.. Human drug-preparation studies exist; these findings do not confirm the chemical composition, efficacy or safety of the supplier’s material. Identity and formulation must be established before interpreting efficacy claims. Related-compound evidence is contextual only. Commercial names, modifications and routes do not establish clinical equivalence. Authors reported functional improvement within complex stroke care. Abstract lacks numeric effect estimates; clinical setting, background care and the exact preparation limit generalization. No healthy-person cognition benefit established. Authors reported improved cognitive and depression scores with Cortexin plus Neuromexol. Combination treatment and observational allocation prevent assigning change to Cortexin alone. Exact supplier identity remains unverified. Risks on the record: Human safety for this exact preparation is incompletely characterized. A lack of reported problems does not establish safety.
We mark the cited papers as D. That is our label for how strong those papers are. It does not say the compound works.
regulatory-context
Identity and formulation must be established before interpreting efficacy claims.
No matched controlled clinical study of this exact preparation was verified in this source audit. Related-compound evidence is contextual only. Commercial names, modifications and routes do not establish clinical equivalence.
human-trial
Authors reported functional improvement within complex stroke care.
272 patients in a multicenter double-blind placebo-controlled trial. Abstract lacks numeric effect estimates; clinical setting, background care and the exact preparation limit generalization. No healthy-person cognition benefit established.
human-observation
Authors reported improved cognitive and depression scores with Cortexin plus Neuromexol.
801 people aged 30–80 with chronic cerebral ischemia and cognitive impairment; 30-day observations. Combination treatment and observational allocation prevent assigning change to Cortexin alone. Exact supplier identity remains unverified.
How long it lasts, how you store it, listed sizes
The catalog does not record a single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule.
Half-life on file: no single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule. Follow the label on the vial you hold. This page does not set a throw-away date after you add water.
U-100 math for listed Cortexin sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.
| Listed vial | 1 mL liquid | 2 mL liquid | 3 mL liquid |
|---|---|---|---|
| 5 mg | 50 | 25 | 16.7 |
| 10 mg | 100 | 50 | 33.3 |
Risks and mix-ups already on the record
- Human safety for this exact preparation is incompletely characterized. A lack of reported problems does not establish safety.
- No complete contraindication list is established for this exact preparation. Review pregnancy, allergies and existing conditions with a clinician.
- No complete interaction study for this exact preparation is verified. Ingredient combinations are not presumed compatible.
People using PepBear often log: Exact product identity, formulation, dated label and any clinician-directed observations. Record symptoms and changes alongside other medicines, sleep and activity; observations do not establish causation.
Sources
- Regulatory context; not efficacy evidence · checked 2026-10-09
- Cortexin: multicenter placebo-controlled stroke study (2014) · checked 2026-10-09
- CORNELia: observational combination-treatment report (2023) · checked 2026-10-09
Questions people ask
Is Cortexin FDA-approved?
not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.
Does PepBear pick an amount of Cortexin?
The calculator turns numbers you type into U-100 units. Trial or label amounts stay as cited facts.
Related cards
Discuss the evidence and unresolved identity or safety questions with a licensed clinician. This entry provides no treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.